Article ID: 10050
Promising therapeutic efficacy and safety of a novel integrin α6-targeting peptide-drug conjugate in lung adenocarcinoma
Published 7 months ago
Lung adenocarcinoma (LUAD) is the most prevalent subtype of lung cancer, with poor prognosis due to rapid tumor growth and resistance to current treatments. Thus, the identification of novel biomarkers and the...
By Wuyou Gao, Qiaoli Wang, Shibing Li, Wanqi Chen, Bin Luo, Kaili Xie, Huaze Liao, Leqi Zhong, Youfang Chen, Zhesheng Wen and Guokai Feng
Loading more articles...